Literature DB >> 1312405

Peripheral motor-sensory neuropathy in membranous lipodystrophy (Nasu's disease): a case report.

S Iannaccone1, L Ferini-Strambi, R Nemni, P Marchettini, M Corbo, P Pinto, S Smirne.   

Abstract

A case of membranous lipodystrophy (ML) with peripheral polyneuropathy (PN) is described. A 40-year-old woman presented with dementia, multiple lytic bone lesions with typical membranous material in adipose tissues and neurophysiological and pathological findings of peripheral neuropathy. We describe the first case of ML with PN. It is interesting since nerve involvement might be an additional cause of symptoms usually attributed to bone lesions.

Entities:  

Mesh:

Year:  1992        PMID: 1312405

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  5 in total

Review 1.  Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia.

Authors:  A Verloes; P Maquet; B Sadzot; M Vivario; A Thiry; G Franck
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Case report 867. Membranous lipodystrophy (polycystic lipomembranous osteodysplasia).

Authors:  N Koçer; S Dervisoglu; G Ersavasti; A Altug; O Cokyüksel
Journal:  Skeletal Radiol       Date:  1994-10       Impact factor: 2.199

3.  Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.

Authors:  P Pekkarinen; I Hovatta; P Hakola; O Järvi; M Kestilä; U Lenkkeri; R Adolfsson; G Holmgren; P O Nylander; L Tranebjaerg; J D Terwilliger; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  [Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy].

Authors:  B Lorch; K Henkel; H Schaab; W Aurnhammer; T Becker
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

Review 5.  The Primary Microglial Leukodystrophies: A Review.

Authors:  Isidro Ferrer
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.